TY  -  
T1  - Faecal microbiota transplantation in patients with Clostridium difficile and significant comorbidities as well as in patients with new indications : A case series 
SN  -  /  
UR  - http://hdl.handle.net/10138/228547 
T3  -  
A1  - Lahtinen, Perttu; Mattila, Eero; Anttila, Veli-Jukka; Tillonen, Jyrki; Teittinen, Matti; Nevalainen, Pasi; Salminen, Seppo; Satokari, Reetta; Arkkila, Perttu 
A2  -  
PB  -  
Y1  - 2017 
LA  - eng 
AB  - Fecal microbiota transplantation (FMT) is effective in recurrent Clostridium difficile infection (rCDI). Knowledge of the safety and efficacy of FMT treatment in immune deficient patients is scarce. FMT has been suggested as a potential method for an increasing number of new indications besides rCDI. Among our FMT-treated rCDI patients, we reviewed those with major comorbidities: two human immunodeficiency virus patients, six haemodialysis patients, two kidney transplant patients, two liver tran... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - Faecal microbiota transplantation; Antibiotic resistance; Clostridium difficile infection; Microbiota; Immunodeficiency; Salmonella infection; ACTIVE ULCERATIVE-COLITIS; CONTROLLED-TRIAL; INFECTION; RECURRENT; CARRIAGE; DISEASE; EFFICACY; THERAPY; UPDATE; GENES; 3121 General medicine, internal medicine and other clinical medicine 
N1  -   
PP  -  
ER  -